Related Experiment Videos
Accuracy of cord blood screening for sickle hemoglobinopathies. Three- to five-year follow-up
Insights
Neonatal screening for sickle hemoglobinopathies using cord blood electrophoresis is highly accurate. This reliable method confirms diagnoses later in childhood, ensuring effective early management of sickle cell disease.
Area of Science:
- Hematology
- Medical Genetics
- Pediatrics
Background:
- Sickle hemoglobinopathies require early diagnosis for strategic management.
- Accurate neonatal screening is crucial for identifying these conditions at birth.
Purpose of the Study:
- To verify the accuracy of neonatal cord blood hemoglobin electrophoresis for diagnosing sickle hemoglobinopathies.
- To assess the long-term diagnostic reliability of initial newborn screening methods.
Main Methods:
- Agar gel and cellulose acetate hemoglobin electrophoresis were used for initial cord blood analysis.
- A cohort of 138 children underwent follow-up testing using cellulose acetate electrophoresis at 3-5 years of age.
- Comparison of initial diagnoses with follow-up results.
Main Results:
- Initial cord blood diagnoses were confirmed in all 138 children.
- All 26 children with major sickle syndromes (SS, S-beta thalassemia, SC) were correctly identified at birth.
- No discrepancies were found between neonatal screening and later childhood diagnoses.
Conclusions:
- Cord blood hemoglobin electrophoresis is a precise method for neonatal diagnosis of sickle hemoglobinopathies.
- The employed electrophoretic techniques provide reliable identification of both major and minor sickle cell conditions.
- Neonatal screening enables accurate early detection, facilitating timely intervention for affected infants.
Abstract:
The strategic advantages of neonatal diagnosis of sickle hemoglobinopathies depend on an accurate cord blood screening procedure. One hundred thirty-eight black children in whom a range of normal and abnormal hemoglobin genotypes was identified by agar gel and cellulose acetate hemoglobin electrophoresis at birth were retested by cellulose acetate three to five years later. The original cord blood diagnoses were verified in all 138, including all 26 with major sickle syndromes (SS, S-beta thalassemia, and SC). Cord blood hemoglobin electrophoresis using these techniques permits accurate neonatal diagnosis of major and minor sickle hemoglobinopathies.